InvestorsHub Logo
Followers 1078
Posts 80316
Boards Moderated 8
Alias Born 03/10/2009

Re: None

Friday, 07/23/2021 11:43:33 AM

Friday, July 23, 2021 11:43:33 AM

Post# of 1226
Curadox BioPharma, Inc. has developed CB-TD1, a novel drug candidate that capitalizes on these observations and the desire to target only those abnormal cells with an increased iron demand. The drug, intended for intravenous administration,is a conjugate compound that utilizes readily available and well-characterized drug substances in an easily reproduced, low cost and stable manufacturing process.

https://curadox.com/

https://www.linkedin.com/in/jim-pekarsky-a5387711

Gelteq Appoints Seasoned Pharma and Tech Executive, James Pekarsky, as Chief Financial Officer



https://www.morningstar.com/news/globe-newswire/8285135/gelteq-appoints-seasoned-pharma-and-tech-executive-james-pekarsky-as-chief-financial-officer

STOP & VISIT MY BOARD AT: HOTTEST PENNY STOCK PICKS

http://investorshub.advfn.com/boards/board.aspx?board_id=19627

My posts are NOT a buy/sell recommendation, Do your Own DD, before you buy any stock - I reserve the right to buy/sell any stock